Aa
Aa
A
A
A
Close
Avatar universal

Oxcarbazepine and Phenytoin

I was recently diagnosed with epilepsy after 4 sycopal episodes two of which cause head and face injuries. During those times I had not yet been diagnosed and was able to go back to life like normal, however after the diagnosis and being on phenytoin and switching to oxcarbazepine i am feeling awful. Dizzy, nauseated, moody, extremely tired, severe headaches that come and go. All i get from my Neurologist is these are side effects that will eventually go away. Because i never know when these symptoms will come on too strong I have missed a lot of days at work during my probation period. I just want a normal life or to be my old self. Any suggestions? Feeling depressed and unmotivated to make plans...
2 Responses
Sort by: Helpful Oldest Newest
Avatar universal
Graphics for Thank You Comments
I really appreciate your comment. I've contacted the RN assisting the Neurologist but they aren't very helpful. I'll try to find another way to contact them.
Helpful - 0
Avatar universal
Hi,

The only thing I can suggest is that you call your doctor and ask to have the medication adjusted. If you are experiencing that much discomfort, it may be the meds are not at the correct level for you.

Good luck and I hope you are feeling better soon.
Helpful - 0
Have an Answer?

You are reading content posted in the Epilepsy Community

Top Neurology Answerers
1780921 tn?1499301793
Queen Creek, AZ
Avatar universal
Minneapolis, MN
Learn About Top Answerers
Didn't find the answer you were looking for?
Ask a question
Popular Resources
Find out how beta-blocker eye drops show promising results for acute migraine relief.
In this special Missouri Medicine report, doctors examine advances in diagnosis and treatment of this devastating and costly neurodegenerative disease.
Here are 12 simple – and fun! – ways to boost your brainpower.
Discover some of the causes of dizziness and how to treat it.
Discover the common causes of headaches and how to treat headache pain.
Two of the largest studies on Alzheimer’s have yielded new clues about the disease